BridgeBio Pharma Inc
NASDAQ:BBIO 3:59:57 PM EDT
Earnings Announcements
Bridgebio Pharma Q2 Loss Per Share $0.07
Published: 08/04/2022 12:12 GMT
BridgeBio Pharma Inc (BBIO) - Bridgebio Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Update.
Bridgebio Pharma Inc - Qtrly Loss per Share $0.07.
Bridgebio Pharma Inc - Qtrly Revenue $73.75 Million Versus $54.0 Million.
Bridgebio Pharma Inc - Qtrly Loss per Share $0.07.
Bridgebio Pharma Inc - Qtrly Revenue $73.75 Million Versus $54.0 Million.
Revenue is expected to be $8.63 Million
Adjusted EPS is expected to be -$0.91
Next Quarter Revenue Guidance is expected to be $9.82 Million
Next Quarter EPS Guidance is expected to be -$0.89
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.91
Next Quarter Revenue Guidance is expected to be $9.82 Million
Next Quarter EPS Guidance is expected to be -$0.89
More details on our Analysts Page.